{"name": "Biocrates Life Sciences",
 "permalink": "biocrates-life-sciences",
 "crunchbase_url": "http://www.crunchbase.com/company/biocrates-life-sciences",
 "homepage_url": "http://www.biocrates.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Mon Apr 26 05:35:28 UTC 2010",
 "updated_at": "Fri Jul 23 03:09:19 UTC 2010",
 "overview": "\u003Cp\u003EBIOCRATES has dedicated its research activities to the youngest addition of the \u00e2\u20ac\u02dcomics\u00e2\u20ac\u2122 quartet of systems biology, i.e., metabolomics, the study of the body\u00e2\u20ac\u2122s\nsmall-molecule metabolites. The metabolomics approach to biomarker development holds particular promise in that it provides a snapshot of the physiological state of an organism as determined by its genetic setup, protein regulation and abundance, and environmental influences. Rather than attempting to elucidate the effect a particular gene or protein may have on the organism, metabolomics looks at the tail end of how diseases or drugs influence the human body.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0008/4900/84900v1-max-150x150.jpg"],
     [[221,
       62],
      "assets/images/resized/0008/4900/84900v1-max-250x250.jpg"],
     [[221,
       62],
      "assets/images/resized/0008/4900/84900v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$7.87M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 6270000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 6,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MIG AG",
         "permalink": "mig-ag",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0006/1641/61641v1-max-150x150.png"],
             [[213,
               71],
              "assets/images/resized/0006/1641/61641v1-max-250x250.png"],
             [[213,
               71],
              "assets/images/resized/0006/1641/61641v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.invest-iq.com/Arax-finances-Biocrates-Life-Sciences",
    "source_description": "Arax Capital Leads Financing Round for Biocrates Life Systems",
    "raised_amount": 1600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MIG AG",
         "permalink": "mig-ag",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0006/1641/61641v1-max-150x150.png"],
             [[213,
               71],
              "assets/images/resized/0006/1641/61641v1-max-250x250.png"],
             [[213,
               71],
              "assets/images/resized/0006/1641/61641v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Arax Capital Partners",
         "permalink": "arax-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0010/0246/100246v1-max-150x150.png"],
             [[189,
               69],
              "assets/images/resized/0010/0246/100246v1-max-250x250.png"],
             [[189,
               69],
              "assets/images/resized/0010/0246/100246v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Innrain 66/2",
    "address2": "",
    "zip_code": "",
    "city": "6020 Innsbruck",
    "state_code": null,
    "country_code": "AUT",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        103],
       "assets/images/resized/0008/4901/84901v1-max-150x150.jpg"],
      [[250,
        172],
       "assets/images/resized/0008/4901/84901v1-max-250x250.jpg"],
      [[450,
        310],
       "assets/images/resized/0008/4901/84901v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}